Amrubicin and carboplatin with pegfilgrastim in patients with extensive-stage small-cell lung cancer (ES-SCLC): A phase II study of the Sarah Cannon Research Institute (SCRI).
Meeting Abstract
Shipley, Dianna, Hainsworth, John D., Mekhail, Tarek, Zubkus, John D., Flora, Douglas B., Daniel, Davey B., Waterhouse, David Michael, Gravenor, Donald, Burris, Howard A., Greco, Frank A., Spigel, David R.